純利益 & Net Margin
SAME PT. Sarana Meditama Metropolitan Tbk
3.772.362,00
220
-28 (-11,29%)
2019
-114.384 (-21.61%)
2020
-449.464 (-88.54%)
2021
138.553 (10.9%)
2022
4.347 (0.31%)
2023
12.252 (0.8%)
IKPM PT. Ikapharmindo Putramas Tbk
367.256,00
218
-6 (-2,68%)
2019
n/a
2020
n/a
2021
n/a
2022
16.577 (4.16%)
2023
15.337 (3.48%)
OMED PT. Jayamas Medica Industri Tbk
5.384.701,00
199
-3 (-1,49%)
2019
n/a
2020
n/a
2021
562.692 (25.27%)
2022
285.781 (16.43%)
2023
259.359 (14.93%)
RSCH PT. Charlie Hospital Semarang Tbk
503.500,00
190
-18 (-8,65%)
2019
n/a
2020
n/a
2021
n/a
2022
n/a
2023
-1.111 (-2.64%)
INAF PT. Indofarma Tbk
473.863,00
149
-2 (-1,33%)
2019
7.961 (0.59%)
2020
27 (0%)
2021
-37.580 (-1.29%)
2022
-428.462 (-37.45%)
2023
n/a
SURI PT. Maja Agung Latexindo Tbk
823.468,00
130
+3 (+2,36%)
2019
n/a
2020
n/a
2021
n/a
2022
10.226 (10.96%)
2023
5.468 (6.69%)
PYFA PT. Pyridam Farma Tbk
1.179.854,00
105
-4 (-3,67%)
2019
9.342 (3.78%)
2020
22.104 (7.97%)
2021
5.478 (0.87%)
2022
275.241 (38.47%)
2023
-85.220 (-12.14%)
CARE PT. Metro Healthcare Indonesia Tbk
2.660.001,00
79
-2 (-2,53%)
2019
-24.205 (-15.71%)
2020
14.312 (6.62%)
2021
6.099 (2.1%)
2022
-93.543 (-39.98%)
2023
-110.919 (-45.71%)
PRIM PT. Royal Prima Tbk
182.429,00
54
-1 (-1,82%)
2019
2.396 (1.38%)
2020
38.169 (14.65%)
2021
75.433 (12.57%)
2022
21.589 (8.24%)
2023
-2.746 (-1.03%)
MMIX PT. Multi Medika Internasional Tbk
122.405,00
51
-1 (-2,00%)
2019
n/a
2020
352 (23.75%)
2021
10.331 (25.52%)
2022
23.668 (13.52%)
2023
16.512 (9.43%)
MEDS PT. Hetzer Medical Indonesia Tbk
78.125,00
50
0 (0%)
2019
n/a
2020
n/a
2021
n/a
2022
237 (0.63%)
2023
-3.570 (-15.71%)
HALO PT. Haloni Jane Tbk
259.900,00
46
+1 (+2,22%)
2019
n/a
2020
n/a
2021
n/a
2022
n/a
2023
16.996 (7.35%)
SCPI PT. Organon Pharma Indonesia Tbk
0
0
0 (0%)
2019
112.652 (6.12%)
2020
218.362 (7.55%)
2021
118.691 (5.5%)
2022
174.782 (7.47%)
2023
187.701 (6.83%)